AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 1,221 | 1,326 | 12,833 | 1,022 | 33,906 |
Gross Profit | 1,221 | 1,326 | 12,833 | 1,022 | 33,906 |
Operating Expenses | 21,668 | 17,605 | 20,383 | 20,071 | 15,662 |
Operating Income | -20,447 | -16,278 | -7,550 | -19,049 | 18,243 |
Interest Expense | 206 | 71 | 462 | 2,195 | 87 |
Other Income | 0 | 18 | 62 | 1,558 | 327 |
Pre-tax Income | -20,652 | -16,331 | -7,950 | -19,686 | 18,483 |
Net Income Continuous | -20,652 | -16,331 | -7,950 | -19,686 | 18,483 |
Net Income | $-20,652 | $-16,331 | $-7,950 | $-19,686 | $18,483 |
EPS Basic Total Ops | -0.28 | -0.23 | -0.11 | -0.31 | 0.25 |
EPS Basic Continuous Ops | -0.29 | -0.23 | -0.11 | -0.31 | 0.26 |
EPS Diluted Total Ops | -0.28 | -0.23 | -0.11 | -0.28 | 0.25 |
EPS Diluted Continuous Ops | -0.29 | -0.23 | -0.11 | -0.27 | 0.26 |
EBITDA(a) | $-19,855 | $-15,674 | $-7,170 | $-18,691 | $18,585 |